ES2649396T3 - Métodos y composiciones para expandir, identificar, caracterizar y mejorar la potencia de células progenitoras restringidas gliales derivadas de mamíferos - Google Patents
Métodos y composiciones para expandir, identificar, caracterizar y mejorar la potencia de células progenitoras restringidas gliales derivadas de mamíferos Download PDFInfo
- Publication number
- ES2649396T3 ES2649396T3 ES10830580.6T ES10830580T ES2649396T3 ES 2649396 T3 ES2649396 T3 ES 2649396T3 ES 10830580 T ES10830580 T ES 10830580T ES 2649396 T3 ES2649396 T3 ES 2649396T3
- Authority
- ES
- Spain
- Prior art keywords
- cells
- div
- grp
- vitro
- days
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0622—Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0081—Purging biological preparations of unwanted cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26044109P | 2009-11-12 | 2009-11-12 | |
| US260441P | 2009-11-12 | ||
| US32679910P | 2010-04-22 | 2010-04-22 | |
| US326799P | 2010-04-22 | ||
| PCT/US2010/055956 WO2011059952A1 (en) | 2009-11-12 | 2010-11-09 | Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2649396T3 true ES2649396T3 (es) | 2018-01-11 |
Family
ID=43991980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES10830580.6T Active ES2649396T3 (es) | 2009-11-12 | 2010-11-09 | Métodos y composiciones para expandir, identificar, caracterizar y mejorar la potencia de células progenitoras restringidas gliales derivadas de mamíferos |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US10351823B2 (https=) |
| EP (2) | EP2499238B1 (https=) |
| JP (2) | JP5952737B2 (https=) |
| CN (2) | CN105602889A (https=) |
| AU (1) | AU2010319680B2 (https=) |
| CA (1) | CA2780541C (https=) |
| DK (1) | DK2499238T3 (https=) |
| ES (1) | ES2649396T3 (https=) |
| NO (1) | NO2499238T3 (https=) |
| PL (1) | PL2499238T3 (https=) |
| WO (1) | WO2011059952A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003070171A2 (en) | 2002-02-15 | 2003-08-28 | Cornell Research Foundation, Inc. | Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| KR20110011658A (ko) | 2008-05-08 | 2011-02-08 | 유니버시티 오브 로체스터 | 최적화된 세포 제제에 의한 수초 질환의 치료 |
| JP6541577B2 (ja) | 2013-02-06 | 2019-07-10 | ユニバーシティー オブ ロチェスター | ミエリン障害の治療のための誘導多能性細胞由来オリゴデンドロサイト前駆細胞 |
| CA2959691A1 (en) * | 2014-09-26 | 2016-03-31 | The Procter & Gamble Company | Products comprising malodor reduction materials |
| US9724432B2 (en) | 2015-04-30 | 2017-08-08 | University Of Rochester | Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder |
| US11690876B2 (en) | 2017-05-10 | 2023-07-04 | University Of Rochester | Methods of treating neuropsychiatric disorders |
| CN108624560B (zh) * | 2018-06-01 | 2022-04-08 | 南京艾尔普再生医学科技有限公司 | 一种分化培养基及少突胶质前体细胞的制备方法 |
| US10995325B2 (en) | 2019-03-21 | 2021-05-04 | Fornia Biosolutions, Inc. | Additional phytase variants and methods |
| KR102322635B1 (ko) * | 2021-06-11 | 2021-11-05 | 인제대학교 산학협력단 | 말초신경양 미세조직 제조방법 및 이의 용도 |
| US20240254440A1 (en) * | 2021-06-30 | 2024-08-01 | The Regents Of The University Of California | Methods to generate glial restricted neural progenitor cells and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6235527B1 (en) * | 1997-11-29 | 2001-05-22 | University Of Utah Research Foundation | Lineage restricted glial precursors from the central nervous system |
| CA2295197A1 (en) | 1999-09-08 | 2001-03-08 | Appleton Papers Inc. | Thermally-responsive record material |
| US6878543B1 (en) * | 1999-10-25 | 2005-04-12 | Nsgene Sa | Cultures of GFAP+ nestin+ cells that differentiate to neurons |
| AR046076A1 (es) * | 2003-07-18 | 2005-11-23 | Otsuka Pharma Co Ltd | Procedimiento para obtener una poblacion homogenea de celulas precursoras de oligodendrocitos y poblacion obtenida |
| US20050272149A1 (en) * | 2004-06-02 | 2005-12-08 | Life & Brain Gmbh | Therapeutic delivery of adenosine into a tissue |
| US20090155223A1 (en) * | 2007-08-14 | 2009-06-18 | The Johns Hopkins University | Cell-based compositions and methods for treating conditions of the nervous system |
-
2010
- 2010-11-09 CA CA2780541A patent/CA2780541C/en active Active
- 2010-11-09 CN CN201610055313.6A patent/CN105602889A/zh active Pending
- 2010-11-09 EP EP10830580.6A patent/EP2499238B1/en active Active
- 2010-11-09 EP EP17188092.5A patent/EP3269803A3/en not_active Withdrawn
- 2010-11-09 AU AU2010319680A patent/AU2010319680B2/en active Active
- 2010-11-09 NO NO10830580A patent/NO2499238T3/no unknown
- 2010-11-09 JP JP2012538881A patent/JP5952737B2/ja active Active
- 2010-11-09 US US13/508,803 patent/US10351823B2/en active Active
- 2010-11-09 PL PL10830580T patent/PL2499238T3/pl unknown
- 2010-11-09 CN CN201080051269.2A patent/CN102686721B/zh active Active
- 2010-11-09 WO PCT/US2010/055956 patent/WO2011059952A1/en not_active Ceased
- 2010-11-09 ES ES10830580.6T patent/ES2649396T3/es active Active
- 2010-11-09 DK DK10830580.6T patent/DK2499238T3/en active
-
2016
- 2016-02-15 JP JP2016026441A patent/JP6346629B2/ja active Active
-
2018
- 2018-09-19 US US16/135,626 patent/US20190032010A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN102686721B (zh) | 2016-02-10 |
| JP6346629B2 (ja) | 2018-06-20 |
| EP2499238A1 (en) | 2012-09-19 |
| HK1174953A1 (zh) | 2013-06-21 |
| EP2499238B1 (en) | 2017-08-30 |
| JP2016146831A (ja) | 2016-08-18 |
| EP3269803A2 (en) | 2018-01-17 |
| AU2010319680B2 (en) | 2014-05-29 |
| NO2499238T3 (https=) | 2018-01-27 |
| CA2780541C (en) | 2015-07-14 |
| PL2499238T3 (pl) | 2018-04-30 |
| DK2499238T3 (en) | 2017-12-04 |
| EP3269803A3 (en) | 2018-04-25 |
| WO2011059952A1 (en) | 2011-05-19 |
| US20120230963A1 (en) | 2012-09-13 |
| CN105602889A (zh) | 2016-05-25 |
| CA2780541A1 (en) | 2011-05-19 |
| EP2499238A4 (en) | 2013-10-02 |
| US10351823B2 (en) | 2019-07-16 |
| CN102686721A (zh) | 2012-09-19 |
| JP2013510570A (ja) | 2013-03-28 |
| AU2010319680A1 (en) | 2012-07-05 |
| US20190032010A1 (en) | 2019-01-31 |
| JP5952737B2 (ja) | 2016-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2649396T3 (es) | Métodos y composiciones para expandir, identificar, caracterizar y mejorar la potencia de células progenitoras restringidas gliales derivadas de mamíferos | |
| Hu et al. | Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells | |
| Gärtner et al. | Use of poly (DL-lactide-ε-caprolactone) membranes and mesenchymal stem cells from the Wharton's jelly of the umbilical cord for promoting nerve regeneration in axonotmesis: in vitro and in vivo analysis | |
| Sandner et al. | Neural stem cells for spinal cord repair | |
| Takahashi et al. | Embryonic neural stem cells transplanted in middle cerebral artery occlusion model of rats demonstrated potent therapeutic effects, compared to adult neural stem cells | |
| Chiba et al. | Transplanted bone marrow stromal cells promote axonal regeneration and improve motor function in a rat spinal cord injury model | |
| ES2796853T3 (es) | Diferenciación dirigida de astrocitos a partir de células madre pluripotentes humanas para uso en el cribado de medicamentos y el tratamiento de la esclerosis lateral amiotrófica (ELA) | |
| JP2013508013A (ja) | 細胞療法戦略を用いた慢性神経組織損傷の治療方法 | |
| Chen et al. | Human umbilical cord Wharton's jelly-derived oligodendrocyte precursor-like cells for axon and myelin sheath regeneration★ | |
| Najafzadeh et al. | Rat hair follicle stem cells differentiate and promote recovery following spinal cord injury | |
| Sethi et al. | Olfactory ensheathing cells promote differentiation of neural stem cells and robust neurite extension | |
| Goulao et al. | iPS cell transplantation for traumatic spinal cord injury | |
| Aoki et al. | Limited functional recovery in rats with complete spinal cord injury after transplantation of whole-layer olfactory mucosa | |
| CN111484977B (zh) | 重编程产生功能性去甲肾上腺素能神经元的方法 | |
| Anderson et al. | Human neural progenitor cell transplants into the subthalamic nucleus lead to functional recovery in a rat model of Parkinson’s disease | |
| US12247218B2 (en) | Expandable cell populations from brain biopsies of living subjects | |
| Kyung et al. | Potential therapeutic clue of skin-derived progenitor cells following cytokine-mediated signal overexpressed in injured spinal cord | |
| Mligiliche et al. | Survival of neural progenitor cells from the subventricular zone of the adult rat after transplantation into the host spinal cord of the same strain of adult rat | |
| HK1174953B (en) | Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells | |
| WO2011121158A2 (es) | Método para la obtención de células precursoras de oligodendrocitos | |
| Canzi | Human stem cells for the treatment of motorneuron diseases: regenerative potential, translatability and development of new biotechnologies. Cellule staminali umane per la cura delle malattie degenerative del motoneurone | |
| Marcia et al. | Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson's Disease |